Opticare has launched an entirely new collection of lenses “meticulously designed” and “catering to premium and costeffective needs, ensuring every customer finds their perfect

Clever bio-inks that sit inside the human body and restore damaged neurons could cure a whole swathe of eye diseases in the next 20

Richard Wylie, Chief Executive Officer of Glaucoma Australia, has resigned after 21 months in the position.

EssilorLuxottica has launched a new partnership program, EssilorLuxottica 360 (EL360), which it says will give independent optometry practices more opportunity to grow.